Vontobel Asset Management’s Novo Nordisk NVO Stock Holding History

Vontobel Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-157,424	Closed	-$4.57M	–	67
2015 Q4	$4.57M	Sell	157,424 -11,428	-7%	-$316K	0.04%	68
2015 Q3	$4.58M	Sell	168,852 -64,562	-28%	-$1.83M	0.04%	71
2015 Q2	$6.39M	Hold	233,414	–	–	0.05%	65
2015 Q1	$6.23M	Buy	233,414 +35,810	+18%	+$825K	0.05%	66
2014 Q4	$4.18M	Hold	197,604	–	–	0.03%	70
2014 Q3	$4.71M	Hold	197,604	–	–	0.04%	73
2014 Q2	$4.57M	Buy	+197,604	New	+$4.36M	0.05%	70

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Vontobel Asset Management's NVO Position: Q1 2016 in Review

Vontobel Asset Management sold out of Novo Nordisk (NVO) in Q1 2016, closing a stake of 157,424 shares — an estimated $4.57M sold.

Vontobel Asset Management first reported a position in NVO in Q2 2014 and held it in 7 quarters. The position peaked at $6.39M in Q2 2015. 535 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

Vontobel Asset Management reported no remaining Novo Nordisk position as of Q1 2016 after selling out during the quarter.
Vontobel Asset Management sold 157,424 Novo Nordisk shares in Q1 2016, an estimated $4.57M.
Vontobel Asset Management first reported a position in Novo Nordisk in Q2 2014 and held it in 7 quarters.
Vontobel Asset Management's Novo Nordisk position peaked at $6.39M in Q2 2015.
535 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Vontobel Asset Management's 13F filing for Q1 2016, filed 18 Apr 2016.